Literature DB >> 16424613

A quantitative bacterial micro-assay for rapid detection of serum phenylalanine in dry blood-spots: application in phenylketonuria screening.

Sadeq Vallian1, Hassan Moeini.   

Abstract

Phenylketonuria is an inherited metabolic disease, which is characterized by increased level of serum phenylalanine (Phe). The quantitative measurement of Phe in the serum is necessary to confirm the disease, and to distinguish phenylketonuria from other forms of hyperphenylalaninemia. In this study, we report a rapid and inexpensive micro-assay for simultaneous detection and quantitative measurement of serum Phe in dry blood-spots. Analysis of the standard curve showed a broad linear Phe range of 120-1800 micromol L(-1). Application of this method in conjunction with the standard Guthrie bacterial inhibition assay and high-pressure liquid chromatography in analyzing 34 samples from phenylketonuria patients and control samples produced comparable results, with the regression equation of Y= 0.994X + 0.996. The advantage of this method over the Guthrie bacterial inhibition assay is its ability to measure the serum Phe quantitatively without false positive results. The method was successfully applied to dried blood-spots as well as serum and whole blood samples. The cost per sample is about 20-50 US cents, which is much less than those of high-pressure liquid chromatography and enzymatic commercial kits. The method can be automated, which is suitable for neonatal and mass phenylketonuria screening, especially in developing countries, where funding is a limiting factor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424613     DOI: 10.1007/BF03194603

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  18 in total

1.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

2.  Enzymatic method for phenylketonuria screening using phenylalanine dehydrogenase.

Authors:  K C Dooley
Journal:  Clin Biochem       Date:  1992-08       Impact factor: 3.281

3.  Rapid determination of phenylalanine and tyrosine in urine and serum by HPLC with electrochemical detection.

Authors:  W T Kok; U A Brinkman; R W Frei
Journal:  J Pharm Biomed Anal       Date:  1983       Impact factor: 3.935

4.  A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, by Robert Guthrie and Ada Susi, Pediatrics, 1963;32:318-343.

Authors:  C C Scriver
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

Review 5.  Monogenic traits are not simple: lessons from phenylketonuria.

Authors:  C R Scriver; P J Waters
Journal:  Trends Genet       Date:  1999-07       Impact factor: 11.639

6.  Fluorometric method for phenylalanine microplate assay adapted for phenylketonuria screening.

Authors:  N S Gerasimova; I V Steklova; T Tuuminen
Journal:  Clin Chem       Date:  1989-10       Impact factor: 8.327

7.  A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.

Authors:  C N Sarkissian; Z Shao; F Blain; R Peevers; H Su; R Heft; T M Chang; C R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Phenylketonuria in Iranian population: a study in institutions for mentally retarded in Isfahan.

Authors:  Sadeq Vallian; Elham Barahimi; Hasan Moeini
Journal:  Mutat Res       Date:  2003-05-15       Impact factor: 2.433

9.  The frequency of PKU and hyperphenylalaninemia in Sweden - a study in institutions for the mentally retarded as well as in neonates.

Authors:  G Holmgren; A Larsson; H Palmstierna; J Alm
Journal:  Clin Genet       Date:  1976-12       Impact factor: 4.438

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  1 in total

1.  Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.

Authors:  Anders Persson; Charlotte Becker; Ida Hansson; Anita Nilsson; Carina Törn
Journal:  Exp Diabetes Res       Date:  2010-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.